NNLX (NNLX) Stock Price & Analysis
NNLX (NNLX) rose 0.00% to USD 0 as of June 10, 2026 at 15:09 UTC, according to Nexqual real-time market data.
NNLX last closed at USD 0; the session ranged USD 0–0 on volume of 100 shares. Market capitalization is —, with a 52-week range of USD 0–0.04 (PNK). Source: Nexqual, June 10, 2026 at 15:09 UTC.
Key Statistics (as of June 10, 2026 at 15:09 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.04 |
| Volume | 100 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (NNLX)
Nexqual's technical model rates NNLX "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 15:09 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (NNLX)
Wall Street analysts rate NNLX "None", per Nexqual as of June 10, 2026 at 15:09 UTC.
| Consensus Rating | None |
|---|
Earnings (NNLX)
Source: Nexqual, June 10, 2026 at 15:09 UTC.
Financials & Fundamentals (NNLX)
| Total Revenue | $1,274 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | -424549.20% |
| Profit Margin | +0.00% |
| ROE | -213.57% |
| Current Ratio | 128.89 |
| Total Cash | $178,185 |
| Total Debt | $0 |
| Free Cash Flow | $-579,582 |
Source: Nexqual, June 10, 2026 at 15:09 UTC.
Financial Health Score (NNLX)
Nexqual rates NNLX's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 15:09 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $178K cash, no debt |
| Cash Flow | Weak — FCF negative: -$580K, burning cash |
| Efficiency | Critical — ROE -214%, ROA -129.9% |
Ownership (NNLX)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 158.79M |
Source: Nexqual, June 10, 2026 at 15:09 UTC.
Leadership (NNLX)
NNLX is led by Bret T. Barnhizer (age 74), Chairman, CEO & President, per Nexqual as of June 10, 2026 at 15:09 UTC.
| Chairman, CEO & President | Bret T. Barnhizer (age 74) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INTK | Industrial Nanotech, Inc. | USD 0 | ▲ 0% |
| MHTX | Manhattan Scientifics, Inc. | USD 0 | ▲ 0% |
| NPHC | Nutra Pharma Corp. | USD 0 | ▲ 50% |
| NNBP | NANOBAC PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| GSPI | Green Star Products, Inc. | USD 0 | ▼ 13.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 15:09 UTC. This page is informational and not investment advice.